89Bio Inc (ETNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -57,420 | -16,176 | N/A | N/A | N/A |
| Depreciation Amortization | 17 | 6 | N/A | N/A | N/A |
| Income taxes - deferred | 20 | -20 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -520 | 1,509 | N/A | N/A | N/A |
| Other Working Capital | 937 | 2,634 | N/A | N/A | N/A |
| Other Operating Activity | 31,506 | -422 | 0 | 0 | 0 |
| Operating Cash Flow | $-25,460 | $-12,469 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -139 | -39 | N/A | N/A | N/A |
| Investing Cash Flow | $-139 | $-39 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 100 | N/A | N/A | N/A |
| Common Stock Issued | 87,702 | 0 | N/A | N/A | N/A |
| Other Financing Activity | 20,000 | 23,665 | 0 | 0 | 0 |
| Financing Cash Flow | $107,702 | $23,765 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 11,257 | 0 | N/A | N/A | N/A |
| End Cash Position | 93,360 | 11,257 | N/A | N/A | N/A |
| Net Cash Flow | $82,103 | $11,257 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,460 | -12,469 | N/A | N/A | N/A |
| Capital Expenditure | -139 | -39 | N/A | N/A | N/A |
| Free Cash Flow | -25,599 | -12,508 | 0 | 0 | 0 |